Talk DIAlogue Sessions track
S1105 - Startup Accelerator
Tue, Mar 18, 2025 · 2:30–4:30 PM CET Delhi Room, Congress Center Basel
About this session
This session gives innovators the opportunity to learn about pathways to communicate effectively with Regulatory Authorities and HTA bodies and discuss challenges in the development of innovative healthcare products. Industry experts, Regulators, HTA Body representatives and patient advocates will share insights into overcoming regulatory hurdles and the benefits of early collaboration in fostering specialised drug development.
Complementary* registration for startups. Healthcare startups looking to accelerate their journey and make a real impact in life sciences are invited to join this interactive session.
*complementary pass for this session and the first day of DIA Europe 2025 (1 pass per company).
Contact Edyta.Maciolek@DIAglobal.org
Learn more
Programme:
- 2. Empowering Small and Medium Enterprises in Specialized Drug Development: Navigating Challenges and Unlocking Opportunities — Anke Arnold-Tugulu
- 8. End Game Thinking - Navigating Regulatory and HTA requirements to develop products which serve patients, regulators and payers alike — Markus Kalousek
- 3. Regulatory pathways — Falk Ehmann
- 4. Clinical Trials — Marianne Lunzer
- 5. HTA — Anja Schiel
- 6. Digital Health — Gurmit Sandhu
- 7. EU funding — Elmar Nimmesgern
- Q&A and Roundtables — Falk Ehmann
- 1. Setting the scene — Falk Ehmann
Speakers
-
Special Advisor, Lead Methodologist; Leader international HTA (iHTA) NoMA · Norwegian Medicines Agency (NoMA)
Speaker
